查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1768729

全球肝癌診斷市場

Liver Cancer Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 275 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球肝癌診斷市場規模將達 220 億美元

全球肝癌診斷市場規模預計在2024年為143億美元，預計到2030年將達到220億美元，2024年至2030年的複合年成長率為7.4%。臨床檢測是本報告分析的細分市場之一，預計其複合年成長率為8.4%，到分析期結束時規模將達到98億美元。影像診斷細分市場在分析期間內的複合年成長率預計為7.5%。

美國市場預計將達到 37 億美元，中國市場複合年成長率將達到 11.1%

美國肝癌診斷市場規模預計2024年達到37億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到53億美元，在2024-2030年的分析期間內，複合年成長率為11.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為3.9%和6.9%。在歐洲，預計德國市場的複合年成長率為4.7%。

全球肝癌診斷市場—主要趨勢與促進因素摘要

如何促進肝癌的早期發現與治療？

肝癌診斷技術正在快速發展，提高了我們在早期發現肝癌的能力，因為早期治療方案更有效。肝癌的診斷工具包括超音波、電腦斷層掃描 (CT) 和磁振造影(MRI) 等影像技術，以及用於測量甲胎蛋白 (AFP) 等生物標記的血液檢測。早期發現至關重要，因為肝癌通常進展緩慢，直到晚期才出現明顯症狀。由於肝炎感染、飲酒和非酒精性脂肪性肝病 (NAFLD) 等因素導致全球肝癌發病率上升，對先進診斷工具的需求也日益成長。

哪些技術創新正在塑造肝癌診斷市場？

診斷技術的創新正在改變肝癌檢測的格局。液態切片是一種分析血液中循環性腫瘤細胞(CTC) 和 DNA 的非侵入性技術，正成為檢測肝癌和監測其進展的新興工具。基因組分析和次世代定序(NGS) 也被整合到肝癌診斷中，以識別可指南個人化治療策略的特定基因突變。此外，人工智慧 (AI) 和機器學習的進步正在透過增強掃描判讀能力和識別傳統方法難以檢測的早期腫瘤來提高肝癌成像的準確性。

市場區隔將如何定義肝癌診斷的成長？

相關技術包括診斷成像、液態切片和生物標記檢測，其中診斷成像佔據最大佔有率，因為它廣泛應用於常規篩檢。應用涵蓋早期檢測、診斷和監測，其中早期檢測需求巨大，因為醫療保健提供者專注於透過及時干預來提高生存率。終端用戶包括醫院、診斷實驗室和研究機構，其中醫院是主要細分市場，因為醫院的肝癌篩檢和治療計劃量很大。從地理來看，由於中國和日本等國家肝癌發生率高，亞太地區的市場正在迅速擴張。

推動肝癌診斷市場成長的因素有哪些？

肝癌診斷市場的成長受到多種因素的推動，包括肝癌發病率的上升、診斷技術的進步以及人們對早期診斷意識的不斷增強。全球肝癌發生率的上升，尤其是在肝炎感染率高的地區，推動了對更準確、更方便的診斷工具的需求。液態切片和人工智慧成像診斷等技術的進步提高了早期檢測的準確性，從而實現了更個人化的治療方法。此外，政府推動癌症篩檢和早期診斷的措施也促進了先進診斷工具的普及，進一步推動了市場的成長。

部分

診斷技術（實驗室檢測、影像、內視鏡檢查、切片檢查和其他診斷技術）、最終用戶（醫院和診斷實驗室、學術和研究機構以及其他最終用戶）

受訪公司範例

  • Abbott Laboratories
  • Becton Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Wako Diagnostics USA Corporation
  • Hologic
  • Illumina Inc.
  • Koninklijke Philips
  • Oncimmune Holdings Plc
  • Qiagen
  • Siemens Healthineers
  • Sirtex Medical ltd.
  • Thermo Fischer Scientific Inc.

人工智慧整合

利用檢驗的專家內容和 AI 工具轉變您的市場和競爭情報。

Global Industry Analysts 並未遵循典型的 LLM 或特定產業的 SLM查詢，而是建立了一個從全球專家收集的內容庫，其中包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP22166

Global Liver Cancer Diagnostics Market to Reach US$22.0 Billion by 2030

The global market for Liver Cancer Diagnostics estimated at US$14.3 Billion in the year 2024, is expected to reach US$22.0 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$9.8 Billion by the end of the analysis period. Growth in the Imaging segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 11.1% CAGR

The Liver Cancer Diagnostics market in the U.S. is estimated at US$3.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.3 Billion by the year 2030 trailing a CAGR of 11.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Liver Cancer Diagnostics Market - Key Trends and Drivers Summarized

How Is Liver Cancer Diagnostics Advancing Early Detection and Treatment?

Liver cancer diagnostics are undergoing rapid advancements, improving the ability to detect liver cancer at earlier stages when treatment options are more effective. Diagnostic tools for liver cancer include imaging techniques such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI), as well as blood tests that measure biomarkers like alpha-fetoprotein (AFP). Early detection is crucial in liver cancer, as the disease often progresses silently with few symptoms until it reaches advanced stages. With rising global rates of liver cancer due to factors such as hepatitis infections, alcohol consumption, and non-alcoholic fatty liver disease (NAFLD), the demand for advanced diagnostic tools is growing.

What Technological Innovations Are Shaping the Liver Cancer Diagnostics Market?

Innovations in diagnostic technologies are transforming the landscape of liver cancer detection. Liquid biopsy, a non-invasive technique that analyzes circulating tumor cells (CTCs) and DNA in the blood, is emerging as a promising tool for detecting liver cancer and monitoring its progression. Genomic profiling and next-generation sequencing (NGS) are also being integrated into liver cancer diagnostics to identify specific genetic mutations that can guide personalized treatment strategies. Additionally, advances in artificial intelligence (AI) and machine learning are improving the accuracy of liver cancer imaging by enhancing the interpretation of scans and identifying early-stage tumors that may be difficult to detect through traditional methods.

How Do Market Segments Define the Growth of Liver Cancer Diagnostics?

Technologies include imaging, liquid biopsy, and biomarker testing, with imaging representing the largest segment due to its widespread use in routine screenings. Applications span early detection, diagnosis, and monitoring, with early detection driving significant demand as healthcare providers focus on improving survival rates through timely intervention. End-users include hospitals, diagnostic laboratories, and research institutions, with hospitals being the primary segment due to the high volume of liver cancer screenings and treatment planning. Geographically, the market is expanding rapidly in Asia-Pacific due to the high prevalence of liver cancer in countries such as China and Japan.

What Factors Are Driving the Growth in the Liver Cancer Diagnostics Market?

The growth in the liver cancer diagnostics market is driven by several factors, including the rising incidence of liver cancer, advancements in diagnostic technologies, and increasing awareness of early detection. As liver cancer rates climb globally, particularly in regions with high hepatitis infection rates, the need for more accurate and accessible diagnostic tools is intensifying. Technological advancements, such as liquid biopsy and AI-enhanced imaging, are improving the precision of early detection, enabling more personalized treatment approaches. Furthermore, government initiatives to promote cancer screenings and early diagnosis are encouraging the adoption of advanced diagnostic tools, further boosting market growth.

SCOPE OF STUDY:

The report analyzes the Liver Cancer Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Diagnosis Technique (Laboratory Tests, Imaging, Endoscopy, Biopsy, Other Diagnosis Techniques); End-Use (Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories
  • Becton Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Wako Diagnostics U.S.A. Corporation
  • Hologic
  • Illumina Inc.
  • Koninklijke Philips
  • Oncimmune Holdings Plc
  • Qiagen
  • Siemens Healthineers
  • Sirtex Medical ltd.
  • Thermo Fischer Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Liver Cancer Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Liver Cancer and Increasing Awareness Drive Growth in Liver Cancer Diagnostics Market
    • Technological Advancements in Imaging and Molecular Diagnostics Strengthen Business Case for Adoption
    • Growing Use of Liquid Biopsies and Biomarker-Based Diagnostics Expands Addressable Market
    • Expansion of Early Detection Programs Fuels Demand for Liver Cancer Diagnostics
    • Increasing Adoption of Non-Invasive Diagnostic Techniques Drives Market Growth
    • Technological Innovations in Next-Generation Sequencing (NGS) Propel Market Growth in Liver Cancer Diagnostics
    • Focus on Enhancing Accuracy and Reducing False Positives Strengthens Demand for Advanced Diagnostic Solutions
    • Growing Use of AI and Machine Learning in Diagnostic Imaging Expands Market Opportunities
    • Rising Demand for Personalized Medicine and Targeted Therapies Fuels Growth in Liver Cancer Diagnostics
    • Technological Advancements in Liquid Biopsy Assays for Early-Stage Detection Propel Market Growth
    • Growing Adoption of Companion Diagnostics in Liver Cancer Treatment Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Liver Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Liver Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Laboratory Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Laboratory Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Endoscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Diagnosis Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Diagnosis Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Diagnosis Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Liver Cancer Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Liver Cancer Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Liver Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Liver Cancer Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Liver Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Liver Cancer Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Liver Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Liver Cancer Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Liver Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Liver Cancer Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Liver Cancer Diagnostics by Diagnosis Technique - Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Liver Cancer Diagnostics by Diagnosis Technique - Percentage Breakdown of Value Sales for Laboratory Tests, Imaging, Endoscopy, Biopsy and Other Diagnosis Techniques for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Liver Cancer Diagnostics by End-Use - Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Liver Cancer Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Diagnostic Laboratories, Academic & Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION